Invizyne

"I’m excited about the technology. It’s definitely revolutionary, in my opinion. [...] I do think their technology is broadly applicable. I believe they have a really good chance to succeed with their technology and the IPO." states National Renewable Energy Laboratory (NREL) research group leader, Yannick Bomble, PhD, in this article about Invizyne preparing an initial public offering (IPO) - the first company from the Shell GameChanger Accelerator Powered by NREL (GCxN) program to do so. Full interview with Tyler Korman and Michael Heltzen available here: https://lnkd.in/dB_YTK2k #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech #nasdaq #IPO

The co-founder of #GCxN portfolio company Invizyne, Tyler Korman, and Yannick Bomble, PhD, distinguished principal scientist at National Renewable Energy Laboratory recently sat down to discuss the potential of Invizyne's game-changing cell-free, enzyme-based #biomanufacturing systems.

Dr. Jim Lalonde: From two years and 25 scientists to a few scientists for a few months "When I started out in 2004, that was the early days of enzyme engineering while we were still developing the tools at that point. One of the projects we worked on was Lipitor [...] I think it was $14 billion a year revenue. [...] The challenges with those kind of programs was that it was two years and 25 scientists to do one enzyme. It was a big, big spend. Now, with Invizyne, it's a few scientists for few months that can do an enzyme. So it'really a couple of orders of magnitude reduction in the amount of RD because of the the tools have gotten so much better. [...] All these things have brought down the cost of RD and increased the target." ~ states synthetic biology key opinion leader, Dr. James J. Lalonde, in an interview. You can see the full interview here: https://lnkd.in/dwT33bBb #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech

"Invizyne is taking what nature has done and [...] putting things in a manufacturing format so we can make materials at low cost and really help the sustainability of this planet." ~ states synthetic biology key opinion leader, Dr. Jim Lalonde, in an interview. You can see the full interview here: https://lnkd.in/dwT33bBb #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech

"What Invizyne is working on is a game changer" ~ states Yannick Bomble, PhD, Group Research Manager III-Biological Science at the National Renewable Energy Laboratory (DoE). The full NREL interview can be seen here: https://lnkd.in/dbZxmKEV #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech

National Renewable Energy Laboratory (DoE) working with Invizyne in their 'Advancing Clean Tech to Energize the Future' project - a fireside chat with Yannick Bomble, PhD, Group Research Manager III-Biological Science at NREL - and - Tyler Korman, PhD, VP of Research at Invizyne - as well as - Lou Basenese, President Chief Market Strategist at MDB Capital. #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF #greentech #cleantech

Commercializing Invizyne’s cell-free platform - a fireside chat with Zachary Karl, Ph.D., Vice President of Business Development at Invizyne - and - Lou Basenese, President & Chief Market Strategist at MDB Capital. #biomanufacturing #nextgenbiomanufacturing #cellfree #enzymes #biochemistry #biochemicals #synbio #syntheticbiology #synbiobeta #biosynthesis #simplepath #scalablebiochemistry #scalable #energytransition #endocannabinoids #cannabinoids #sustainableaviationfuel #SAF

Invizyne - now with an investor-focused webpage! Lots of info about us relevant to the upcoming Nasdaq IPO (SEC compliant): https://lnkd.in/g28UUWET

If you want to see me pitch Invizyne and our business plans to some of the investors, who are joining us via our IPO at Nasdaq next month, here is a recording of just that: https://lnkd.in/g93sxE6g

Thank you for having us and for the good conversations!